Transcode Therapeutics Stock

Transcode Therapeutics Market capitalization

The The market capitalization of Transcode Therapeutics (RNAZ) as of Aug 16, 2026 is 8.54 M USD. In the previous year, The market capitalization was 8.54 M USD — a change of 0.00% (lower).

Market capitalization

8.54 MUSD

YoY

0.00%

Last updated:

In 2026, Transcode Therapeutics's market cap stood at 8.54 M USD, a 0.00% increase from the 8.54 M USD market cap in the previous year.

The Transcode Therapeutics Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Capitalization (undefined USD)
Date
Market Capitalization (undefined USD)
Jan 1, 2023
0.00 base
Jan 1, 2024
0.00 base
Jan 1, 2025 (e)
0.00 base
Jan 1, 2026 (e)
0.00 base
Jan 1, 2027 (e)
0.00 base
Jan 1, 2028 (e)
0.00 base
Jan 1, 2029 (e)
0.00 base
Jan 1, 2030 (e)
0.00 base
YEARMarket Capitalization (undefined USD)
2030 est -
2029 est -
2028 est -
2027 est -
2026 est -
2025 est -
2024 -
2023 -
2022 -
2021 -
2020 -
2019 -
2018 -
Access this data via the Eulerpool API

Transcode Therapeutics Stock analysis

What does Transcode Therapeutics do? Transcode Therapeutics is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Transcode Therapeutics's Market Capitalization

Transcode Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Transcode Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Transcode Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Transcode Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Transcode Therapeutics stock

The market capitalization of Transcode Therapeutics is 8.54 M USD in 2026.

The market capitalization of Transcode Therapeutics changed from 8.54 M USD to 8.54 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Transcode Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Transcode Therapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Transcode Therapeutics

All Key Metrics — Transcode Therapeutics